W. L. Gore & Associates (Gore) announced the availability of a 31 mm diameter version of the GORE EXCLUDER AAA Endoprosthesis. This device provides physicians with a effective and safe endovascular option to treat abdominal aortic aneurysms (AAAs) in patients with aortic inner neck diameters up to 29 mm. Other important enhancements include a flat-top design which enables greater production efficiency, an additional pair of proximal anchors that helps ensure excellent fixation, and a lengthening of the trunk from 7 to 8 cm so as to accommodate larger anatomies. Worldwide more than 87,000 GORE EXCLUDER Devices have been implanted in patients, making it a widely accepted, minimally invasive treatment option for patients with AAA. The US Food and Drug Administration (FDA) in March 2009 approved the 31 mm diameter version. It has been available outside of the US since 2004 and has been implanted in more than 3,300 patients. The GORE EXCLUDER AAA Endoprosthesis uses a minimally invasive procedure thereby reducing the hospital stay, mortality and morbidity associated with surgery. The Gore device is an endovascular graft and stent combination which seals off the aneurysm and creates a new path for blood flow. Using a catheter-based delivery technique the device is inserted through a small incision in the patient’s leg. Once the physician has positioned the graft in the diseased aorta, it self-expands using radial force. Metal anchors help secure it to the walls of the aorta. The 31 mm GORE EXCLUDER Device is available in 13, 15 and 17 cm lengths. A new 32 mm x 4.5 cm Aortic Extender Component joins the device family as well. Both the new Trunk-Ipsilateral Leg and Aortic Extender Components are 20 Fr introducer sheath compatible.